Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer's Disease

被引:1
|
作者
Gentreau, Melissa [1 ]
Raymond, Michel [2 ]
Samieri, Cecilia [3 ]
Chuy, Virginie [3 ,4 ]
Feart, Catherine [3 ]
Berticat, Claire [2 ]
Artero, Sylvaine [1 ]
机构
[1] Univ Montpellier, Inst Funct Genom IGF, CNRS, INSERM, F-34094 Montpellier, France
[2] Univ Montpellier, EPHE, CNRS, IRD,ISEM, F-34095 Montpellier, France
[3] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, BPH,UMR 1219, F-33000 Bordeaux, France
[4] CHU Bordeaux, Pole Med & Chirurg Bucco Dent, F-33000 Bordeaux, France
关键词
glycemic load; refined carbohydrate; amyloid-beta; Alzheimer's disease; biomarker; cohort; APOLIPOPROTEIN-E; DIABETES-MELLITUS; RISK; INSULIN; DEMENTIA; INTERVENTION; CARBOHYDRATE; METABOLISM; MODULATION; PEPTIDES;
D O I
10.3390/nu14122485
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Previous studies have highlighted links between a high-glycemic-load (GL) diet and Alzheimer's disease in apolipoprotein E epsilon 4 (APOE4) carriers. However, the impact of high-GL diet on plasma amyloid-beta (A beta), an Alzheimer's disease hallmark that can be detected decades before clinical symptomatology, is unknown. This study examined the association between plasma A beta peptides (A beta(40), A beta(42) concentration and A beta(42)/A beta(40) ratio) and GL. The influence of the GL of four meal types (breakfast, lunch, afternoon snack, and dinner) was also determined. From the prospective Three-City study, 377 participants with plasma A beta measurements, and who completed the Food Frequency Questionnaire, were selected. The association between plasma A beta and GL was tested using an adjusted linear regression model. Lunch GL was associated with a lower plasma A beta(42) concentration (beta = -2.2 [CI = -4.27,-0.12], p = 0.038) and lower A beta(42)/A beta(40) ratio (beta = -0.009 [CI = -0.0172, -0.0007], p = 0.034) in the model adjusted for center, age, sex, education level, APOE4 status, energy intake, serum creatinine, total cholesterol, and Mediterranean-like diet. No significant association was found with the GL of the other meal types. These results suggest that dietary GL may independently modulate the plasma A beta of the APOE4 status. The mechanism underlying diet, metabolic response, and A beta peptide regulation must be elucidated.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] High performance plasma amyloid-β biomarkers for Alzheimer’s disease
    Akinori Nakamura
    Naoki Kaneko
    Victor L. Villemagne
    Takashi Kato
    James Doecke
    Vincent Doré
    Chris Fowler
    Qiao-Xin Li
    Ralph Martins
    Christopher Rowe
    Taisuke Tomita
    Katsumi Matsuzaki
    Kenji Ishii
    Kazunari Ishii
    Yutaka Arahata
    Shinichi Iwamoto
    Kengo Ito
    Koichi Tanaka
    Colin L. Masters
    Katsuhiko Yanagisawa
    [J]. Nature, 2018, 554 : 249 - 254
  • [2] High performance plasma amyloid-β biomarkers for Alzheimer's disease
    Nakamura, Akinori
    Kaneko, Naoki
    Villemagne, Victor L.
    Kato, Takashi
    Doecke, James
    Dore, Vincent
    Fowler, Chris
    Li, Qiao-Xin
    Martins, Ralph
    Rowe, Christopher
    Tomita, Taisuke
    Matsuzaki, Katsumi
    Ishii, Kenji
    Ishii, Kazunari
    Arahata, Yutaka
    Iwamoto, Shinichi
    Ito, Kengo
    Tanaka, Koichi
    Masters, Colin L.
    Yanagisawa, Katsuhiko
    [J]. NATURE, 2018, 554 (7691) : 249 - +
  • [3] Plasma amyloid-β biomarkers are associated with Alzheimer′s disease comorbidity in Lewy body disease
    Noguchi-Shinohara, Moeko
    Murakami, Hidetomo
    Sakashita, Yasuhiro
    Mori, Yukiko
    Komatsu, Junji
    Muramatsu, Daiki
    Hikishima, Sadao
    Ono, Kenjiro
    [J]. PARKINSONISM & RELATED DISORDERS, 2023, 111
  • [4] Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
    Kaj Blennow
    Harald Hampel
    Henrik Zetterberg
    [J]. Neuropsychopharmacology, 2014, 39 : 189 - 201
  • [5] Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
    Blennow, Kaj
    Hampel, Harald
    Zetterberg, Henrik
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (01) : 189 - 201
  • [6] Describing biomarkers for Alzheimer's disease: Localization of amyloid-β in the retina
    Xu, Qinyuan
    Lee, Sieun
    Hirsch-Reinshagen, Veronica
    Mackenzie, Ian
    Hsiung, Robin
    Cao, Sijia
    Jiang, Kailun
    Sarunic, Marinko
    Beg, Mirza
    Cui, Jing Z.
    Matsubara, Joanne A.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [7] Application of Bezier Curves for Calculating Likelihood Ratios for Plasma Amyloid-β Biomarkers for Alzheimer's Disease
    Fierz, Walter
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [8] Plasma Amyloid-β Forms in Alzheimer's Disease and Non-Alzheimer's Disease Patients
    Le Bastard, Nathalie
    Leurs, Judith
    Blomme, Walter
    De Deyn, Peter Paul
    Engelborghs, Sebastiaan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (01) : 291 - 301
  • [9] Plasma amyloid-β concentrations in Alzheimer's disease:: an alternative hypothesis
    Oprisiu, Roxana
    Serot, Jean-Marie
    Godefroy, Olivier
    Black, Sandra E.
    Fournier, Albert
    [J]. LANCET NEUROLOGY, 2006, 5 (12): : 1001 - 1002
  • [10] Intracellular amyloid-β in Alzheimer's disease
    LaFerla, Frank M.
    Green, Kim N.
    Oddo, Salvatore
    [J]. NATURE REVIEWS NEUROSCIENCE, 2007, 8 (07) : 499 - 509